EG18335A - Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and antherosclerosis - Google Patents

Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and antherosclerosis

Info

Publication number: EG18335A
Authority: EG; Egypt
Prior art keywords: hyperlipidaemia; treatment; pyridoxine; antherosclerosis; prevention
Prior art date: 1987-02-18

Application number

EG53/88A

Other languages

English (en)

Original Assignee

Speck Ulrich

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-18

Filing date

1988-02-01

Publication date

1992-09-30

1988-02-01 Application filed by Speck Ulrich filed Critical Speck Ulrich

1992-09-30 Application granted granted Critical

1992-09-30 Publication of EG18335A publication Critical patent/EG18335A/xx

Links

208000031226 Hyperlipidaemia Diseases 0.000 title abstract 2
150000003227 pyridoxines Chemical class 0.000 title abstract 2
238000011282 treatment Methods 0.000 title abstract 2
230000002265 prevention Effects 0.000 title 1
RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 2
NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 abstract 2
NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 abstract 2
201000001320 Atherosclerosis Diseases 0.000 abstract 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
229940009098 aspartate Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229930195712 glutamate Natural products 0.000 abstract 1
238000011866 long-term treatment Methods 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
235000008164 pyridoxal Nutrition 0.000 abstract 1
239000011674 pyridoxal Substances 0.000 abstract 1
229960003581 pyridoxal Drugs 0.000 abstract 1
235000007682 pyridoxal 5'-phosphate Nutrition 0.000 abstract 1
239000011589 pyridoxal 5'-phosphate Substances 0.000 abstract 1
229960001327 pyridoxal phosphate Drugs 0.000 abstract 1
235000008151 pyridoxamine Nutrition 0.000 abstract 1
239000011699 pyridoxamine Substances 0.000 abstract 1
ZMJGSOSNSPKHNH-UHFFFAOYSA-N pyridoxamine 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(CN)=C1O ZMJGSOSNSPKHNH-UHFFFAOYSA-N 0.000 abstract 1
WHOMFKWHIQZTHY-UHFFFAOYSA-N pyridoxine 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(CO)=C1O WHOMFKWHIQZTHY-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)

EG53/88A 1987-02-18 1988-02-01 Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and antherosclerosis EG18335A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19873705549 DE3705549A1 (de)	1987-02-18	1987-02-18	Verwendung von pyridoxin-derivaten bei der prophylaxe und therapie von hyperlipidaemien und atherosklerose

Publications (1)

Publication Number	Publication Date
EG18335A true EG18335A (en)	1992-09-30

Family

ID=6321453

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG53/88A EG18335A (en)	1987-02-18	1988-02-01	Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and antherosclerosis

Country Status (12)

Country	Link
EP (1)	EP0282696B1 (fr)
JP (2)	JPH0710777B2 (fr)
KR (1)	KR950009094B1 (fr)
AT (1)	ATE82125T1 (fr)
CA (1)	CA1340246C (fr)
DE (2)	DE3705549A1 (fr)
DK (1)	DK55888A (fr)
EG (1)	EG18335A (fr)
ES (1)	ES2052609T3 (fr)
GR (1)	GR3006693T3 (fr)
HU (1)	HUT47850A (fr)
ZA (1)	ZA88577B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6740668B1 (en)	1995-08-28	2004-05-25	Kansas University Medical Center	Methods for inhibiting diabetic complications
US6228858B1 (en)	1995-09-12	2001-05-08	University Of Kansas Medical Center	Advanced glycation end-product intermediaries and post-amadori inhibition
US6716858B1 (en)	1995-08-28	2004-04-06	Kansas University Medical Center	Methods for inhibiting diabetic complications
US6730686B1 (en)	1995-09-12	2004-05-04	Kansas University Medical Center	Methods for inhibiting oxidative modification of proteins
US5744451A (en)	1995-09-12	1998-04-28	Warner-Lambert Company	N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US6750209B1 (en)	1995-09-12	2004-06-15	Kansas University Medical Center	Advanced glycation end-product intermediaries and post-amadori inhibition
US7030146B2 (en)	1996-09-10	2006-04-18	University Of South Carolina	Methods for treating diabetic neuropathy
US6043259A (en) *	1998-07-09	2000-03-28	Medicure Inc.	Treatment of cardiovascular and related pathologies
WO2000022094A2 (fr) *	1998-10-09	2000-04-20	Kansas University Medical Center	Procede permettant d'inhiber la modification oxydative des proteines
CA2366602A1 (fr)	1999-03-08	2000-09-14	Medicure Inc.	Analogues de pyridoxal destines aux troubles provoques par une carence en vitamine b6
CA2376029A1 (fr)	1999-07-13	2001-01-18	Medicure Inc.	Traitement du diabete et des pathologies associees
US6677356B1 (en)	1999-08-24	2004-01-13	Medicure International Inc.	Treatment of cardiovascular and related pathologies
US7442689B2 (en)	2000-02-29	2008-10-28	Medicure International Inc.	Cardioprotective phosphonates and malonates
WO2001064692A1 (fr)	2000-02-29	2001-09-07	Medicure International Inc.	Phosphonates et malonates cardioprotecteurs
CA2404329A1 (fr)	2000-03-28	2001-10-04	Medicure International Inc.	Traitement d'une maladie vasculaire cerebrale
NZ523815A (en)	2000-07-07	2004-07-30	Medicure Int Inc	Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en)	2001-07-06	2003-04-15	Medicure International Inc.	Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en)	2000-07-07	2005-05-24	Medicure International Inc.	Pyridoxine and pyridoxal analogues: new uses
JP2006523206A (ja) *	2003-03-27	2006-10-12	メディキュアインコーポレーテッド	細胞死の調節
EP1817288A4 (fr)	2004-10-28	2009-08-26	Medicure Int Inc	Analogues de pyridoxine à double activité anti-plaquettes et anti-coagulantes
JP2008526783A (ja) *	2005-01-05	2008-07-24	メディキュア・インターナショナル・インコーポレーテッド	トリグリセリドレベルを調節するための化合物及び方法
FR3038227B1 (fr)	2015-06-30	2018-08-17	Assistance Publique - Hopitaux De Paris	Formulation effervescente a base de pyridoxal-5-phosphate
WO2020003363A1 (fr) *	2018-06-25	2020-01-02	学校法人近畿大学	Supplément nutritionnel ou composition pharmaceutique pour prévenir la détérioration des vaisseaux sanguins due à l'impact de l'ingestion de nicotine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR6707M (fr) *	1966-04-29	1969-02-17
GB1070120A (en) *	1966-05-06	1967-05-24	Tanabe Seiyaku Co	Pyridoxine derivative and the preparation thereof
FR7238M (fr) *	1968-03-27	1969-09-01
FR2035765A1 (en) *	1969-03-06	1970-12-24	Inst Rech Scient	Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates
FR2176509A2 (en) *	1972-03-21	1973-11-02	Inst Rech Scient	Pyridoxine p-chlorophenoxyisobutyrate prodn - giving very pure product from corresp acid and pyridoxine
JPS5018470A (fr) *	1973-05-31	1975-02-26
CH607773A5 (en) *	1974-12-24	1978-10-31	Steigerwald Arzneimittelwerk	Process for the preparation of novel pyridoxine derivatives
DE2461742C2 (de) *	1974-12-28	1983-01-27	Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt	Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2349330A1 (fr) *	1976-04-29	1977-11-25	Savini Emile	Composition destinee au traitement des hyperlipidemies
JPS5347110A (en) *	1976-10-12	1978-04-27	Osaka Bosui Kensetsusha Kk	Impermeable wall forming method
US6152775A (en)	1998-12-07	2000-11-28	Framatome Connectors Interlock, Inc.	Filtered electrical connector with multiple ferrite members

1987
- 1987-02-18 DE DE19873705549 patent/DE3705549A1/de not_active Withdrawn
1988
- 1988-01-20 DE DE8888100747T patent/DE3875760D1/de not_active Expired - Fee Related
- 1988-01-20 EP EP88100747A patent/EP0282696B1/fr not_active Expired - Lifetime
- 1988-01-20 AT AT88100747T patent/ATE82125T1/de not_active IP Right Cessation
- 1988-01-20 ES ES88100747T patent/ES2052609T3/es not_active Expired - Lifetime
- 1988-01-28 ZA ZA880577A patent/ZA88577B/xx unknown
- 1988-02-01 EG EG53/88A patent/EG18335A/xx active
- 1988-02-03 DK DK055888A patent/DK55888A/da not_active Application Discontinuation
- 1988-02-16 HU HU88723A patent/HUT47850A/hu unknown
- 1988-02-17 KR KR1019880001692A patent/KR950009094B1/ko not_active Expired - Fee Related
- 1988-02-17 JP JP63032943A patent/JPH0710777B2/ja not_active Expired - Lifetime
- 1988-02-18 CA CA000559285A patent/CA1340246C/fr not_active Expired - Fee Related
1992
- 1992-12-28 GR GR920403159T patent/GR3006693T3/el unknown
1994
- 1994-09-02 JP JP6209830A patent/JP2588686B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE3875760D1 (de)	1992-12-17
JPH07238020A (ja)	1995-09-12
DK55888A (da)	1988-08-19
ATE82125T1 (de)	1992-11-15
DE3705549A1 (de)	1988-09-01
EP0282696A3 (en)	1989-06-14
KR950009094B1 (ko)	1995-08-14
EP0282696A2 (fr)	1988-09-21
KR880009649A (ko)	1988-10-04
CA1340246C (fr)	1998-12-15
HUT47850A (en)	1989-04-28
ES2052609T3 (es)	1994-07-16
JP2588686B2 (ja)	1997-03-05
JPS63203621A (ja)	1988-08-23
EP0282696B1 (fr)	1992-11-11
DK55888D0 (da)	1988-02-03
ZA88577B (en)	1988-07-28
JPH0710777B2 (ja)	1995-02-08
GR3006693T3 (fr)	1993-06-30

Publication	Publication Date	Title
EG18335A (en)	1992-09-30	Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and antherosclerosis
KR950009098B1 (en)	1995-08-14	Pharmaceutical composition for use in treating clot formation
AU2490297A (en)	1998-01-08	Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis
AU7316591A (en)	1991-09-18	Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
HU896498D0 (en)	1990-03-28	Process for preparation of low volatility salts
DE69230526D1 (de)	2000-02-10	Polyaminosäure-dispergiermittel
EP0273800A3 (en)	1988-07-20	Hirudine variants, their use and preparation
AU2005188A (en)	1989-02-02	Pharmaceutical composition for intranasal administration comprising gh-releasing hormone, a cholinergic agonist and in case a bile salt
GR900300043T1 (en)	1991-07-31	Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
AU639097B2 (en)	1993-07-15	Medicament for treating hyperlipidaemia and/or atherosclerosis
PL306371A1 (en)	1995-03-20	Diamine salts of clavulanic acid
AU1463888A (en)	1988-11-03	Nitrification-inhibiting agent
GR3001277T3 (en)	1992-08-26	Chlorpheniramine therapy
AU3934689A (en)	1990-02-15	New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
IL81549A0 (en)	1987-09-16	Pharmaceutical compositions containing glycerophosphoryl-o-serine or a salt thereof,certain such novel salts and their preparation
EP0286802A3 (fr)	1992-01-08	Emploi de l'ofloxacine pour le traitement ou la prophylaxie topique des troubles péridontiques
HU9200025D0 (en)	1992-03-30	Medical preparations for treating depression
EP0290186A3 (fr)	1989-04-05	Utilisation de compositions buccales contenant des agents anti-plaque dentaire
GR3024980T3 (en)	1998-01-30	Synergistic combination of decarboxylase inhibitors and L-dopa pellets
ZA871140B (en)	1988-09-28	Synergistic chemical compositions for treating salmonellosis
GB2206338B (en)	1992-03-04	Fine filler dentifrice
IL92438A0 (en)	1990-07-26	Amine salts of 1,4,2-oxazaphospholidine-4-acetic acid,2-alkoxy-2-oxides and herbicidal compositions
DE3869772D1 (fr)	1992-05-07
AU6686490A (en)	1991-05-30	Pesticide composition
AU619124C (en)	1992-07-30	Salts of N5,N10-methylene-5,6,7,8-tetrahydrofolic acid